EMA401

Showing 1 posts of 1 posts found.

Novartis spends $200m on pain firm Spinifex

June 29, 2015
Sales and Marketing Cosentyx, EMA401, Novartis, Secukinumab, spinifex

Novartis is spending $200 million to increase its presence in pain management through the purchase of US-Australian biotech Spinifex Pharmaceuticals.  …

The Gateway to Local Adoption Series

Latest content